WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Linaclotide active metabolite MM-419447

Governed registry record

1 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.

    DOI: 10.1124/jpet.112.199430PMID: 23090647

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Busby RW
  • Kessler MM
  • Bartolini WP
  • Bryant AP
  • Hannig G
  • Higgins CS
  • Solinga RM
  • Tobin JV
  • Wakefield JD
  • Kurtz CB
  • Currie MG